Proqr Therapeutics N.V. - (PRQR) closed at $1.31 on November 10, 2026, down 5.1% from the previous close, on volume of 245,680 shares (30-day average 860,814).
Data as of November 10, 2026.
10-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Oct 12, 2026 | Call Spread | 16-Apr-272 : 7.5 C | 1,280 |
| 2-3 | The next 2 largest trades are for Premium members. Start a 7-day free trial | |||
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 9, 2026. See the 10 largest for 30, 60 and 90 days
ProQR to Present Clinical and Preclinical Progress from AX-0810 and AX-0811 at Upcoming Conferences
Globe Newswire (Wed, 28-Oct 8:00 AM ET)
Globe Newswire (Wed, 23-Sep 8:00 AM ET)
Globe Newswire (Wed, 9-Sep 8:00 AM ET)
ProQR to Participate in Upcoming Investor Conferences in September 2026
Globe Newswire (Wed, 2-Sep 8:00 AM ET)
ProQR Announces Second Quarter 2026 Operating and Financial Results
Globe Newswire (Thu, 13-Aug 7:00 AM ET)
ProQR Unveils Clinical Pipeline Expansion with Multiple Catalysts Approaching in 2026–2027
Market Chameleon (Thu, 9-Apr 6:31 AM ET)
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.
Proqr Therapeutics N.V. - trades on the NASDAQ stock market under the symbol PRQR.
As of November 10, 2026, PRQR stock price declined to $1.31 with 245,680 million shares trading.
PRQR has a beta of 2.62, meaning it tends to be more sensitive to market movements. PRQR has a correlation of 0.17 to the broad based SPY ETF.
PRQR has a market cap of $184.87 million. This is considered a Micro Cap stock.
Last quarter Proqr Therapeutics N.V. - reported $10 million in Revenue and -$.09 earnings per share. This beat revenue expectation by $5 million and exceeded earnings estimates by $.05.
In the last 3 years, PRQR traded as high as $4.62 and as low as $1.07.
PRQR has underperformed the market in the last year with a return of -41.0%, while the SPY ETF gained +12.9%. In the last 3 month period, PRQR fell short of the market, returning -30.1%, while SPY returned -2.8%. However, in the most recent 2 weeks PRQR has outperformed the stock market by returning +5.6%, while SPY returned -2.0%.
PRQR support price is $1.31 and resistance is $1.45 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PRQR shares will trade within this expected range on the day.
